|
|||||
|
|
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized,double-blind,placebo-controlled,phase 3 study (ADAPT) |
|
| Authors: | Saccà Francesco Barnett Carolina Vu Tuan Peric Stojan Phillips Glenn A. Zhao Sihui Qi Cynthia Z. Gelinas Deborah Chiroli Silvia Verschuuren Jan J. G. M. |
| Affiliation: | 1.Federico II University of Naples, Naples, Italy ;2.Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital/UHN, Toronto, ON, Canada ;3.University of South Florida Morsani College of Medicine, Tampa, FL, USA ;4.University of Belgrade—Faculty of Medicine, University Clinical Center of Serbia—Neurology Clinic, Belgrade, Serbia ;5.argenx US, Inc., Boston, MA, USA ;6.argenx Switzerland SA, Geneva, Switzerland ;7.University Medical Center, RC Leiden, Netherlands ; |
| Abstract: | Journal of Neurology - There are substantial disease and health-related quality-of-life (HRQoL) burdens for many patients with myasthenia gravis (MG), especially for those whose disease symptoms... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |